Cargando…

Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease

OBJECTIVE: This study aimed to investigate the international scientific output regarding the relationship between COVID-19 and cardiovascular diseases (CVDs) through a bibliometric analysis and explore research hotspots in this field. METHODS: We searched the Web of Science Core Collection for publi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yiru, Cao, Buzi, Zhou, Quan, Liu, Yantong, He, Qingnan, Zhao, Mingyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880207/
https://www.ncbi.nlm.nih.gov/pubmed/36712251
http://dx.doi.org/10.3389/fcvm.2022.1070336
_version_ 1784878856865316864
author Chen, Yiru
Cao, Buzi
Zhou, Quan
Liu, Yantong
He, Qingnan
Zhao, Mingyi
author_facet Chen, Yiru
Cao, Buzi
Zhou, Quan
Liu, Yantong
He, Qingnan
Zhao, Mingyi
author_sort Chen, Yiru
collection PubMed
description OBJECTIVE: This study aimed to investigate the international scientific output regarding the relationship between COVID-19 and cardiovascular diseases (CVDs) through a bibliometric analysis and explore research hotspots in this field. METHODS: We searched the Web of Science Core Collection for publications and used different types of software, such as R, CiteSpace, and VOSviewer, to analyze and visualize the data. RESULTS: A total of 10,055 publications were retrieved as of the 13 December 2022, based on the inclusion criteria after screening. The USA and China lead in the quantity and quality of publications in this field. Based on Bradford's law, 63 journals were considered core journals in the field. Co-cited references and keywords analysis indicated that researchers paid particular attention to cardiovascular comorbidities, outcomes, and COVID-19 regenerative medicine. In summary, with increasing COVID-19 research related to CVD, more attention might be drawn to the relationship between these two diseases. CONCLUSION: The hotspots in this field may continue to revolve around cardiovascular comorbidities, outcomes, and COVID-19 regenerative medicine. Owing to the different situations faced by different groups with COVID-19, further exploration of the related factors specific to each of these groups, e.g., history or no history of heart failure, is needed, with a view to providing a reference for intervention measures in COVID-19 research.
format Online
Article
Text
id pubmed-9880207
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98802072023-01-28 Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease Chen, Yiru Cao, Buzi Zhou, Quan Liu, Yantong He, Qingnan Zhao, Mingyi Front Cardiovasc Med Cardiovascular Medicine OBJECTIVE: This study aimed to investigate the international scientific output regarding the relationship between COVID-19 and cardiovascular diseases (CVDs) through a bibliometric analysis and explore research hotspots in this field. METHODS: We searched the Web of Science Core Collection for publications and used different types of software, such as R, CiteSpace, and VOSviewer, to analyze and visualize the data. RESULTS: A total of 10,055 publications were retrieved as of the 13 December 2022, based on the inclusion criteria after screening. The USA and China lead in the quantity and quality of publications in this field. Based on Bradford's law, 63 journals were considered core journals in the field. Co-cited references and keywords analysis indicated that researchers paid particular attention to cardiovascular comorbidities, outcomes, and COVID-19 regenerative medicine. In summary, with increasing COVID-19 research related to CVD, more attention might be drawn to the relationship between these two diseases. CONCLUSION: The hotspots in this field may continue to revolve around cardiovascular comorbidities, outcomes, and COVID-19 regenerative medicine. Owing to the different situations faced by different groups with COVID-19, further exploration of the related factors specific to each of these groups, e.g., history or no history of heart failure, is needed, with a view to providing a reference for intervention measures in COVID-19 research. Frontiers Media S.A. 2023-01-13 /pmc/articles/PMC9880207/ /pubmed/36712251 http://dx.doi.org/10.3389/fcvm.2022.1070336 Text en Copyright © 2023 Chen, Cao, Zhou, Liu, He and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Chen, Yiru
Cao, Buzi
Zhou, Quan
Liu, Yantong
He, Qingnan
Zhao, Mingyi
Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease
title Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease
title_full Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease
title_fullStr Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease
title_full_unstemmed Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease
title_short Bibliometric evaluation of 2020–2022 publications on COVID-19-related cardiovascular disease
title_sort bibliometric evaluation of 2020–2022 publications on covid-19-related cardiovascular disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880207/
https://www.ncbi.nlm.nih.gov/pubmed/36712251
http://dx.doi.org/10.3389/fcvm.2022.1070336
work_keys_str_mv AT chenyiru bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease
AT caobuzi bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease
AT zhouquan bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease
AT liuyantong bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease
AT heqingnan bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease
AT zhaomingyi bibliometricevaluationof20202022publicationsoncovid19relatedcardiovasculardisease